Apr 23, 2020 7:30am EDT Algernon Receives Regulatory and Ethics Approval for Phase 2 Ifenprodil COVID-19 Human Study in South Korea
Apr 22, 2020 7:30am EDT Algernon Submits Application to Health Canada for Ifenprodil COVID-19 Phase 2b/3 Multinational Clinical Trial
Apr 15, 2020 8:30am EDT Algernon Receives Positive Feedback from U.S. FDA for New Ifenprodil Intravenous Formulation
Apr 13, 2020 11:34am EDT Algernon CEO and CSO to be Featured on BioPub Webcast Hosted by Dr. KSS MD PhD
Apr 13, 2020 8:30am EDT Algernon Receives Positive Feedback from U.S. FDA for Ifenprodil COVID-19 Human Trial; Appoints U.S. Ambassador (Rtd) Howard Gutman to Advisory Board
Apr 09, 2020 8:30am EDT Algernon Announces Regulatory Submission for Ifenprodil COVID-19 Human Trial in South Korea
Apr 08, 2020 8:30am EDT Algernon Announces Positive Feedback from Health Canada for Ifenprodil COVID-19 Phase 2 Human Trial
Mar 24, 2020 8:30am EDT Algernon Provides an Overview of its NP-120 (Ifenprodil) Program for COVID-19
